106 related articles for article (PubMed ID: 31930344)
1. Transcription Factor ZNF326 Upregulates the Expression of ERCC1 and HDAC7 and its Clinicopathologic Significance in Glioma.
Wang M; Han Q; Su Z; Yu X
Lab Med; 2020 Jul; 51(4):377-384. PubMed ID: 31930344
[TBL] [Abstract][Full Text] [Related]
2. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
Yu X; Wang M; Wu J; Han Q; Zhang X
J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
[TBL] [Abstract][Full Text] [Related]
3. ZNF326 promotes proliferation of non-small cell lung cancer cells by regulating ERCC1 expression.
Wu J; Zhang X; Han Q; Han X; Rong X; Wang M; Zheng X; Wang E
Lab Invest; 2019 Feb; 99(2):169-179. PubMed ID: 30401956
[TBL] [Abstract][Full Text] [Related]
4. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
5. ZNF326 promotes colorectal cancer epithelial-mesenchymal transition.
Yang Y; Yan T; Han Q; Zhang M; Zhang Y; Luo Y; Wei L; Li P; Wang E
Pathol Res Pract; 2021 Sep; 225():153554. PubMed ID: 34332402
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase HDAC4 promotes the proliferation and invasion of glioma cells.
Cai JY; Xu TT; Wang Y; Chang JJ; Li J; Chen XY; Chen X; Yin YF; Ni XJ
Int J Oncol; 2018 Dec; 53(6):2758-2768. PubMed ID: 30272277
[TBL] [Abstract][Full Text] [Related]
7. Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas.
Chen HY; Shao CJ; Chen FR; Kwan AL; Chen ZP
Int J Cancer; 2010 Apr; 126(8):1944-1954. PubMed ID: 19626585
[TBL] [Abstract][Full Text] [Related]
8. FBXW7 induces apoptosis in glioblastoma cells by regulating HDAC7.
Nie X; Jia W; Li X; Pan X; Yin R; Liu N; Su Z
Cell Biol Int; 2021 Oct; 45(10):2150-2158. PubMed ID: 34288252
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
[TBL] [Abstract][Full Text] [Related]
10. Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.
Wu X; Feng F; Yang C; Zhang M; Cheng Y; Zhao Y; Wang Y; Che F; Zhang J; Heng X
J Mol Neurosci; 2019 Dec; 69(4):527-537. PubMed ID: 31377983
[TBL] [Abstract][Full Text] [Related]
11. Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.
Murata H; Yoshimoto K; Hatae R; Akagi Y; Mizoguchi M; Hata N; Kuga D; Nakamizo A; Amano T; Sayama T; Iihara K
J Neurooncol; 2015 Oct; 125(1):33-41. PubMed ID: 26272600
[TBL] [Abstract][Full Text] [Related]
12. [The mRNA expression of BRCA1, ERCC1, TUBB3, PRR13 genes and their relationship with clinical chemosensitivity in primary epithelial ovarian cancer].
Zhao D; Zhang W; Li XG; Wang XB; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):196-200. PubMed ID: 22780973
[TBL] [Abstract][Full Text] [Related]
13. Relationship between methylation status of ERCC1 promoter and radiosensitivity in glioma cell lines.
Liu ZG; Chen HY; Cheng JJ; Chen ZP; Li XN; Xia YF
Cell Biol Int; 2009 Oct; 33(10):1111-7. PubMed ID: 19664717
[TBL] [Abstract][Full Text] [Related]
14. DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis.
Chen DQ; Yao DX; Zhao HY; Yang SJ
Asian Pac J Cancer Prev; 2012; 13(6):2791-4. PubMed ID: 22938460
[TBL] [Abstract][Full Text] [Related]
15. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
16. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of an ERCC1 Immunohistochemistry Assay for Solid Tumors.
Bahamon BN; Gao F; Danaee H
Arch Pathol Lab Med; 2016 Dec; 140(12):1397-1403. PubMed ID: 27610644
[TBL] [Abstract][Full Text] [Related]
18. ERCC1 and ERCC2 polymorphisms and adult glioma.
Wrensch M; Kelsey KT; Liu M; Miike R; Moghadassi M; Sison JD; Aldape K; McMillan A; Wiemels J; Wiencke JK
Neuro Oncol; 2005 Oct; 7(4):495-507. PubMed ID: 16212814
[TBL] [Abstract][Full Text] [Related]
19. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract][Full Text] [Related]
20. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
